AstraZeneca (AZN) Earnings
|
Expand Research on AZN
| Next EPS Date | 4/25/24 | EPS Growth Rate | -50.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +113.2% | Revenue Growth Rate | +8.4% |
| Average % Move 1-Wk after EPS | +1.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/25/24 | Q124 | N/A | $0.96 | N/A | N/A | $11.79B | N/A | N/A | N/A | ||
| 2/8/24 | Q423 | N/A | $0.74 | N/A | $12.02B | $12B | N/A | N/A | N/A | ||
| 11/9/23 | Q323 | $1.73 | $0.86 | +$0.87 | $11.49B | $11.54B | N/A |  | | Details | |
| 7/28/23 | Q223 | $2.15 | $0.99 | +$1.16 | $11.42B | $11.02B | N/A | | | Details | |
| 4/27/23 | Q123 | N/A | $1.72 | N/A | $10.88B | $10.69B | N/A | N/A | N/A | ||
| 2/9/23 | Q422 | N/A | $0.68 | N/A | N/A | $11.27B | N/A | N/A | N/A | ||
| 11/10/22 | Q322 | $1.67 | $0.77 | +$0.90 | $10.98B | $10.78B | N/A | | | Details | |
| 7/29/22 | Q222 | $1.72 | $0.79 | +$0.93 | $10.77B | $10.51B | N/A | | | Details |
